Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.

Danduga RCSR, Dondapati SR, Kola PK, Grace L, Tadigiri RVB, Kanakaraju VK.

Biomed Pharmacother. 2018 Sep;105:1254-1268. doi: 10.1016/j.biopha.2018.06.079. Epub 2018 Jun 22.

0

0

0

PUBMED

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

0

0

0

PUBMED

Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington's disease.

Vallée A, Lecarpentier Y, Guillevin R, Vallée JN.

Rev Neurosci. 2018 Jan 5. pii: /j/revneuro.ahead-of-print/revneuro-2017-0075/revneuro-2017-0075.xml. doi: 10.1515/revneuro-2017-0075. [Epub ahead of print] Review.

0

0

0

PUBMED

Factors contributing to clinical picture and progression of Huntington's disease.

Zielonka D.

Neural Regen Res. 2018 Aug;13(8):1364-1365. doi: 10.4103/1673-5374.235241. No abstract available.

0

0

0

PUBMED

New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

J Int Neuropsychol Soc. 2018 Aug 16:1-9. doi: 10.1017/S1355617718000474. [Epub ahead of print]

0

0

0

PUBMED

OPTICAL COHERENCE TOMOGRAPHY (OCT) STUDY IN ARGENTINEAN HUNTINGTON'S DISEASE PATIENTS.

Gatto E, Parisi V, Persi G, Rey EF, Cesarini M, Etcheverry JL, Rivera P, Squitieri F.

Int J Neurosci. 2018 Jun 18:1-18. doi: 10.1080/00207454.2018.1489807. [Epub ahead of print]

0

0

0

PUBMED

Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

Szejko N, Picón C, García-Caldentey J, de Yebenes JG, Alvarez-Cermeño JC, Villar LM, López-Sendón Moreno JL.

PLoS Curr. 2018 Aug 31;10. pii: ecurrents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da. doi: 10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da.

0

0

0

PUBMED

Spontaneous Intracranial Hypotension as a Cause of Exacerbation in Huntington's Disease.

Figueroa EL, Jog MS, Pelz DM, Lownie SP.

Can J Neurol Sci. 2018 May;45(3):357-359. doi: 10.1017/cjn.2017.296. No abstract available.

0

0

0

PUBMED

Does arterial hypertension influence the onset of Huntington's disease?

Valcárcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, García-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H; REGISTRY investigators of the European Huntington’s Disease Net

PLoS One. 2018 May 23;13(5):e0197975. doi: 10.1371/journal.pone.0197975. eCollection 2018.

0

0

0

PUBMED

Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington's disease.

López-Hurtado A, Burgos DF, González P, Dopazo XM, González V, Rábano A, Mellström B, Naranjo JR.

Mol Brain. 2018 Mar 9;11(1):13. doi: 10.1186/s13041-018-0359-6.

0

0

0

PUBMED

Degeneration of ipRGCs in mouse models of Huntington's Disease disrupts non-image forming behaviors prior to motor impairment.

Lin M, Liao P, Chen H, Chang C, Chen S, Chern Y.

J Neurosci. 2018 Dec 26. pii: 0571-18. doi: 10.1523/JNEUROSCI.0571-18.2018. [Epub ahead of print]

0

0

0

PUBMED

Progress in the Diagnosis and Management of Chorea-acanthocytosis.

Liu Y, Liu ZY, Wan XH, Guo Y.

Chin Med Sci J. 2018 Mar 30;33(1):53-59. doi: 10.24920/21802.

0

0

0

PUBMED

Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.

Singh BK, Vatsa N, Nelson VK, Kumar V, Kumar SS, Mandal SC, Pal M, Jana NR.

Mol Neurobiol. 2018 Jan 2. doi: 10.1007/s12035-017-0853-3. [Epub ahead of print]

0

0

0

PUBMED

Rare case of chorea-hyperglycaemia-basal ganglia (C-H-BG) syndrome.

Ahmad S, Mohan Babu P, Shenbagaraj L, George L.

BMJ Case Rep. 2018 Apr 17;2018. pii: bcr-2017-223920. doi: 10.1136/bcr-2017-223920.

0

0

0

PUBMED

Therapy development in Huntington disease: From current strategies to emerging opportunities.

Dickey AS, La Spada AR.

Am J Med Genet A. 2018 Apr;176(4):842-861. doi: 10.1002/ajmg.a.38494. Epub 2017 Dec 8. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy